All News ResMed, Inc.

Equities

Market Closed - Nyse Other stock markets 21:00:02 29/04/2024 BST			5-day change	1st Jan Change
217.2 ^USD	-0.40%		+20.43%	+26.26%

04-26	Sector Update: Health Care Stocks Edge Higher Late Afternoon	MT
04-26	Top Midday Gainers	MT

ResMed : Q3 2024 ResMed Earnings Results Webcast Transcript	01:19am	PU
Morgans rates RMD as Add	04-29	AQ
ResMed Silences The Doubters	04-29	AQ
Sector Update: Health Care Stocks Edge Higher Late Afternoon	04-26	MT
Top Midday Gainers	04-26	MT
Sector Update: Health Care Stocks Higher in Afternoon Trading	04-26	MT
In-Line Inflation Data, Tech Earnings Lift US Equity Indexes	04-26	MT
Sector Update: Health Care	04-26	MT
KeyBanc Adjusts Price Target on ResMed to $238 From $227	04-26	MT
ResMed's Fiscal Q3 Non-GAAP Earnings, Revenue Increase; Shares Up Over 17%	04-26	MT
Jefferies Adjusts Price Target on ResMed to $180 From $164	04-26	MT
Oppenheimer Adjusts ResMed Price Target to $200 From $205, Maintains Outperform Rating	04-26	MT
JPMorgan Adjusts Price Target on ResMed to $225 From $198	04-26	MT
Mizuho Adjusts Price Target on ResMed to $220 From $215	04-26	MT
Needham Adjusts Price Target on ResMed to $236 From $224	04-26	MT
Morgan Stanley Adjusts Price Target on ResMed to $219 From $207	04-26	MT
RBC Adjusts Price Target on ResMed to $200 From $187	04-26	MT
ResMed Declares Quarterly Dividend as Fiscal Q3 Profit Jumps 29%; Shares Up 7%	04-26	MT
ResMed tops quarterly profit estimates on strong demand for sleep apnea devices	04-25	RE
ResMed : Q3 2024 ResMed Earnings Results Webcast Corporate 1-Pager	04-25	PU

No results for this search

ResMed, Inc. continues to make headway in the sleep market

December 11, 2023 at 10:55 am